Brian’s practice focuses on biotech and pharmaceutical intellectual property disputes with a focus on Hatch-Waxman patent litigation. His practice also includes performing diligence on IP portfolios regarding the patentability of inventions, the validity of patents and the freedom to operate new technologies. Prior to joining the firm, Brian worked for over a decade as a pharmaceutical research and development scientist. During his pharmaceutical career, Brian conducted original research and was responsible for several research groups that focused on products for variety of medical conditions, including: asthma, allergies, cardiovascular, anti-inflammation, hematology, and oncology. Brian has litigated and counseled clients on matters involving biopharmaceuticals, medical devices, small molecule drug substances and drug products.
- Fordham University School of Law
- Seton Hall University
(Ph.D., Chemistry, 2007)
- Rutgers University
(B.S., Biochemistry, 1999)